Clinical applications of hallucinogens: A review

Albert Garcia-Romeu, Brennan Kersgaard, Peter H. Addy

Research output: Contribution to journalArticle

Abstract

Hallucinogens fall into several different classes, as broadly defined by pharmacological mechanism of action, and chemical structure. These include psychedelics, entactogens, dissociatives, and other atypical hallucinogens. Although these classes do not share a common primary mechanism of action, they do exhibit important similarities in their ability to occasion temporary but profound alterations of consciousness, involving acute changes in somatic, perceptual, cognitive, and affective processes. Such effects likely contribute to their recreational use. However, a growing body of evidence indicates that these drugs may have therapeutic applications beyond their potential for abuse. This review will present data on several classes of hallucinogens with a particular focus on psychedelics, entactogens, and dissociatives, for which clinical utility has been most extensively documented. Information on each class is presented in turn, tracing relevant historical insights, highlighting similarities and differences between the classes from the molecular to the behavioral level, and presenting the most up-to-date information on clinically oriented research with these substances, with important ramifications for their potential therapeutic value.

Original languageEnglish (US)
Pages (from-to)229-268
Number of pages40
JournalExperimental and Clinical Psychopharmacology
Volume24
Issue number4
DOIs
StatePublished - Aug 1 2016

Fingerprint

Hallucinogens
Molecular Mechanisms of Pharmacological Action
Aptitude
Consciousness
Therapeutics
Research
Pharmaceutical Preparations

Keywords

  • Club drugs
  • Dissociative
  • Drug policy
  • Hallucinogen
  • Psychedelic

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Psychiatry and Mental health

Cite this

Clinical applications of hallucinogens : A review. / Garcia-Romeu, Albert; Kersgaard, Brennan; Addy, Peter H.

In: Experimental and Clinical Psychopharmacology, Vol. 24, No. 4, 01.08.2016, p. 229-268.

Research output: Contribution to journalArticle

Garcia-Romeu, Albert ; Kersgaard, Brennan ; Addy, Peter H. / Clinical applications of hallucinogens : A review. In: Experimental and Clinical Psychopharmacology. 2016 ; Vol. 24, No. 4. pp. 229-268.
@article{fdb2caef008c463fbba242e471d62f0b,
title = "Clinical applications of hallucinogens: A review",
abstract = "Hallucinogens fall into several different classes, as broadly defined by pharmacological mechanism of action, and chemical structure. These include psychedelics, entactogens, dissociatives, and other atypical hallucinogens. Although these classes do not share a common primary mechanism of action, they do exhibit important similarities in their ability to occasion temporary but profound alterations of consciousness, involving acute changes in somatic, perceptual, cognitive, and affective processes. Such effects likely contribute to their recreational use. However, a growing body of evidence indicates that these drugs may have therapeutic applications beyond their potential for abuse. This review will present data on several classes of hallucinogens with a particular focus on psychedelics, entactogens, and dissociatives, for which clinical utility has been most extensively documented. Information on each class is presented in turn, tracing relevant historical insights, highlighting similarities and differences between the classes from the molecular to the behavioral level, and presenting the most up-to-date information on clinically oriented research with these substances, with important ramifications for their potential therapeutic value.",
keywords = "Club drugs, Dissociative, Drug policy, Hallucinogen, Psychedelic",
author = "Albert Garcia-Romeu and Brennan Kersgaard and Addy, {Peter H.}",
year = "2016",
month = "8",
day = "1",
doi = "10.1037/pha0000084",
language = "English (US)",
volume = "24",
pages = "229--268",
journal = "Experimental and Clinical Psychopharmacology",
issn = "1064-1297",
publisher = "American Psychological Association Inc.",
number = "4",

}

TY - JOUR

T1 - Clinical applications of hallucinogens

T2 - A review

AU - Garcia-Romeu, Albert

AU - Kersgaard, Brennan

AU - Addy, Peter H.

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Hallucinogens fall into several different classes, as broadly defined by pharmacological mechanism of action, and chemical structure. These include psychedelics, entactogens, dissociatives, and other atypical hallucinogens. Although these classes do not share a common primary mechanism of action, they do exhibit important similarities in their ability to occasion temporary but profound alterations of consciousness, involving acute changes in somatic, perceptual, cognitive, and affective processes. Such effects likely contribute to their recreational use. However, a growing body of evidence indicates that these drugs may have therapeutic applications beyond their potential for abuse. This review will present data on several classes of hallucinogens with a particular focus on psychedelics, entactogens, and dissociatives, for which clinical utility has been most extensively documented. Information on each class is presented in turn, tracing relevant historical insights, highlighting similarities and differences between the classes from the molecular to the behavioral level, and presenting the most up-to-date information on clinically oriented research with these substances, with important ramifications for their potential therapeutic value.

AB - Hallucinogens fall into several different classes, as broadly defined by pharmacological mechanism of action, and chemical structure. These include psychedelics, entactogens, dissociatives, and other atypical hallucinogens. Although these classes do not share a common primary mechanism of action, they do exhibit important similarities in their ability to occasion temporary but profound alterations of consciousness, involving acute changes in somatic, perceptual, cognitive, and affective processes. Such effects likely contribute to their recreational use. However, a growing body of evidence indicates that these drugs may have therapeutic applications beyond their potential for abuse. This review will present data on several classes of hallucinogens with a particular focus on psychedelics, entactogens, and dissociatives, for which clinical utility has been most extensively documented. Information on each class is presented in turn, tracing relevant historical insights, highlighting similarities and differences between the classes from the molecular to the behavioral level, and presenting the most up-to-date information on clinically oriented research with these substances, with important ramifications for their potential therapeutic value.

KW - Club drugs

KW - Dissociative

KW - Drug policy

KW - Hallucinogen

KW - Psychedelic

UR - http://www.scopus.com/inward/record.url?scp=84979912950&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979912950&partnerID=8YFLogxK

U2 - 10.1037/pha0000084

DO - 10.1037/pha0000084

M3 - Article

C2 - 27454674

AN - SCOPUS:84979912950

VL - 24

SP - 229

EP - 268

JO - Experimental and Clinical Psychopharmacology

JF - Experimental and Clinical Psychopharmacology

SN - 1064-1297

IS - 4

ER -